Aarti Pharmalabs Ltd

543748

Summary

Fair Value Assessment
Overvalued (29% Premium)
Fair ValueQ593.41UncertaintyHigh
Close Price767.35May 09, 2025
Market Closed
767.35
Price Up by 21.50 | 2.88 %
Previous Close
767.35
Day Range
710.20 – 775.50
Year Range
486.30 – 837.00
Bid / Ask
Market Cap
69.5 Bil
Volume / Average
36.4 k / 38.3 k
Beta (1-Year)
Shares Outstanding
90.63 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.
Contact
Mulund Goregaon Link Road 2nd floor, 204, Udyog Kshetra, Mumbai, MH 400080
T +91 2269436100
www.aartipharmalabs.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
3,183

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
20.20 18.16 19.36 11.92
Revenue Growth %
10.82% -6.22% 62.41%
Gross Profit
8.24 7.01 5.31 3.12
Gross Profit Margin %
40.77% 38.59% 27.40% 26.20%
Operating Income
3.53 3.13 2.81 1.65
Operating Margin %
17.48% 17.23% 14.52% 13.86%
EBIT
3.64 3.15 2.79 1.56
EBIT Margin %
18.01% 17.33% 14.44% 13.06%
EBITDA
4.47 3.88 3.42 1.98
EBITDA Margin %
22.13% 21.37% 17.67% 16.60%
Net Income
2.49 2.17 1.93 1.22
Net Profit Margin %
12.34% 11.95% 9.99% 10.26%
Basic EPS
27.51 23.93 21.35 13.49
Diluted EPS
27.50 23.93 21.35 13.49
Normalized EPS
27.36 23.56 21.73
Total Dividends per Share
3.00 2.00
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
27,765.12 25,821.05 22,309.27 20,399.01 2.50
Total Liabilities
9,197.85 8,250.66 6,724.41 6,534.22 0.22
Total Debt
3,864.70 2,852.54 2,153.13 3,414.01 0.17
Total Equity
18,567.27 17,570.39 15,584.87 13,864.80 2.28
Cash And Cash Equivalents
408.08 236.35 249.30 832.73 2.50
Working Capital
6,931.86 6,512.52 5,641.94 4,474.84 2.28
Shares Outstanding (Mil)
90.63 90.63
Book Value Per Share
204.88 193.85 171.97
Total Debt To Equity
0.21 0.16 0.14 0.25 0.08
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
2.11 2.16 2.63 -0.44
Cash From Investing Activities
-2.92 -2.15 -1.58 -1.39
Cash From Financing Activities
1.10 0.10 -1.63 2.60
Capital Expenditures
2.99 1.99 1.20 1.41
Free Cash Flow
0.44 1.22 1.40 0.34
Change in Cash
0.29 0.12 -0.58 0.78

Profile

Executives shows executive data in a table format includes information on Key Executives, Board of Directors.
Name (Age)
5-Year Trend
2021
2022
2023
2024
2025
Hetal Gogri Gala (—) Vice Chairman of the Board and Managing Director
Narendra Jagannath Salvi (—) Director and Managing Director
Total Compensation for all Key Executives
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top